OBJECTIVES: The choice of the cardiac preservation solution for myocardial protection at time of heart procurement remains controversial and uncertainties persist regarding its effect on the early and midterm heart transplantation (HTx) outcomes. We retrospectively compared our adult HTx performed with 2 different solutions, in terms of hospital mortality, mid-term survival, inotropic score, primary graft dysfunction and rejection score. METHODS: From January 2009 to December 2020, 154 consecutive HTx of adult patients, followed up in pre- and post-transplantation by 2 different tertiary centres, were performed at the University Hospital of Lausanne, Switzerland. From 2009 to 2015, the cardiac preservation solution used was exclusively St-Thomas, whereafter an institutional decision was made to use HTK-Custodiol only. Patients were classified in 2 groups accordingly. RESULTS: There were 75 patients in the St-Thomas group and 79 patients in the HTK-Custodiol group. The 2 groups were comparable in terms of preoperative and intraoperative characteristics. Postoperatively, compared to the St-Thomas group, the Custodiol group patients showed significantly lower inotropic scores [median (interquartile range): 35.7 (17.5–60.2) vs 71.8 (31.8–127), P < 0.001], rejection scores [0.08 (0.0–0.25) vs 0.14 (0.05–0.5), P = 0.036] and 30-day mortality rate (2.5% vs 14.7%, P = 0.007) even after adjusting for potential confounders. Microscopic analysis of the endomyocardial biopsies also showed less specific histological features of subendothelial ischaemia (3.8% vs 17.3%, P = 0.006). There was no difference in primary graft dysfunction requiring postoperative extracorporeal membrane oxygenation. The use of HTK-Custodiol solution significantly improved midterm survival (Custodiol versus St-Thomas: hazard ratio = 0.20, 95% confidence interval: 0.069–0.60, P = 0.004). CONCLUSIONS: This retrospective study comparing St-Thomas solution and HTK-Custodiol as myocardial protection during heart procurement showed that Custodiol improves outcomes after HTx, including postoperative inotropic score, rejection score, 30-day mortality and midterm survival.
3 February 2025 in Journal of Clinical and Translational Research
Background: Iatrogenic type A dissections can be managed conservatively, but clear guidelines for treatment are lacking. Case presentation: This case illustrates a borderline situation that necessitated a change in treatment approach. A patient underwent endo-prosthetic treatment for an aneurysm. During the insertion of a guiding catheter through the axillary artery, the ascending aorta was dissected, with contrast injected into the vascular wall. Due to the mechanism of injury and the absence of an intra-aortic intimal tear (as evidenced by contrast stagnation in the false lumen), conservative management was initially chosen. A follow-up computed tomography (CT) scan showed complete resolution after 1 month. However, 10 days later, the patient was readmitted with acute chest pain, and a new CT scan revealed an acute dissection, with a free-moving intimal flap in the ascending aorta, requiring emergency surgery. Current guidelines recommend surgery for iatrogenic type A dissections that extend or propagate several centimeters into the ascending aorta. However, these guidelines do not account for the mechanism of injury, the localization, or the size of the intimal tear. Conclusion: In this case, the assumption of spontaneous healing with an intact intima was initially supported. However, further developments highlight the importance of clinical and radiological follow-up, regardless of the injury’s mechanism. Relevance for patients: Iatrogenic aortic dissection is a highly complex condition that requires close monitoring and, if necessary, a reassessment of the chosen treatment strategy.